Germ line variants predispose to both JAK2 V617F clonal hematopoiesis and myeloproliferative neoplasms

Germ line variants predispose to both JAK2 V617F clonal hematopoiesis and myeloproliferative neoplasms

Guardat en:

Dades bibliogràfiques
Autors principals:	David A. Hinds, Kimberly E. Barnholt, Ruben A. Mesa, Amy K. Kiefer, Joshua Shulman, Nicholas Eriksson, Joanna L. Mountain, Uta Francke, Joyce Y. Tung, Huong Nguyen, Haiyu Zhang, Linda Gojenola, James L. Zehnder, Jason Gotlib
Format:	Artigo
Idioma:	anglès
Publicat:	2016
Accés en línia:	https://doi.org/10.1182/blood-2015-06-652941
Etiquetes:	Afegir etiqueta Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars

Germ line variants predispose to both JAK2 V617F clonal hematopoiesis and myeloproliferative neoplasms
per: Hinds, David A., et al.
Publicat: (2016)

JAK2(V617F)-mutant Vascular Niche Contributes to JAK2(V617F) Clonal Expansion in Myeloproliferative Neoplasms
per: Lin, Chi Hua Sarah, et al.
Publicat: (2016)

Clonal Hematopoiesis and JAK2V617F Mutations in Patients With Cardiovascular Disease
per: Yokokawa, Tetsuro, et al.
Publicat: (2021)

The JAK2 V617F mutation occurs in hematopoietic stem cells in polycythemia vera and predisposes toward erythroid differentiation
per: Jamieson, Catriona H. M., et al.
Publicat: (2006)

Jmjd1c is dispensable for healthy adult hematopoiesis and Jak2(V617F)-driven myeloproliferative disease initiation in mice
per: Staehle, Hans F., et al.
Publicat: (2020)

The JAK2V617F-bearing vascular niche promotes clonal expansion in myeloproliferative neoplasms
per: Zhan, H, et al.
Publicat: (2018)

The JAK2V617F-bearing vascular niche promotes clonal expansion in myeloproliferative neoplasms
per: Huichun Zhan, et al.
Publicat: (2017)

The <i>JAK2</i> V617F mutation occurs in hematopoietic stem cells in polycythemia vera and predisposes toward erythroid differentiation
per: Catriona Jamieson, et al.
Publicat: (2006)

Clonal Hematopoiesis and Mutations of Myeloproliferative Neoplasms
per: Kjær, Lasse
Publicat: (2020)

Characterization of Murine JAK2V617F-Positive Myeloproliferative Disease
per: Thomas G.P. Bumm, et al.
Publicat: (2006)

Lnk inhibits myeloproliferative disorder-associated JAK2 mutant, JAK2V617F
per: Gery, Sigal, et al.
Publicat: (2009)

JAK2 and Beyond: JAK2V617 Mutational Study of Myeloproliferative Disorders and Haematological Malignancies
per: Syeed, Nidda
Publicat: (2019)

Lnk inhibits myeloproliferative disorder-associated JAK2 mutant, JAK2V617F
per: Sigal Gery, et al.
Publicat: (2009)

TNFα facilitates clonal expansion of JAK2(V617F) positive cells in myeloproliferative neoplasms
per: Fleischman, Angela G., et al.
Publicat: (2011)

TNFα facilitates clonal expansion of JAK2V617F positive cells in myeloproliferative neoplasms
per: Angela G. Fleischman, et al.
Publicat: (2011)

Clonal hematopoiesis in children with predisposing conditions
per: Enrico Attardi, et al.
Publicat: (2024)

Leukemic blasts in transformed JAK2-V617F–positive myeloproliferative disorders are frequently negative for the JAK2-V617F mutation.
per: Alexandre Theocharides, et al.
Publicat: (2007)

A New Murine Model of Clonal Hematopoiesis Investigates JAK2(V617F) in Heart Failure
per: Patel, Aniruddh P., et al.
Publicat: (2019)

JAK2(V617F)-Mediated Clonal Hematopoiesis Accelerates Pathological Remodeling in Murine Heart Failure
per: Sano, Soichi, et al.
Publicat: (2019)

Hematopoietic JAK2(V617F)-mediated clonal hematopoiesis: AIM2 understand mechanisms of atherogenesis
per: Sano, Soichi, et al.
Publicat: (2021)

JAK2 V617F: A Single Mutation in the Myeloproliferative Group of Disorders
per: McLornan, Donal, et al.
Publicat: (2006)

The JAK2 V617F mutation in Philadelphia‐negative chronic myeloproliferative disorders
per: Stój, Anastazja, et al.
Publicat: (2007)

Transgenic expression of JAK2(V617F) causes myeloproliferative disorders in mice
per: Xing, Shu, et al.
Publicat: (2008)

Jak2V617F myeloproliferative neoplasm stem cells and interferon-alpha
per: Lane, Steven W., et al.
Publicat: (2013)

Gender and Vascular Complications in the JAK2 V617F-Positive Myeloproliferative Neoplasms
per: Stein, Brady L., et al.
Publicat: (2011)

Detection of JAK2 V617F mutation increases the diagnosis of myeloproliferative neoplasms
per: ZHANG, SHU-PENG, et al.
Publicat: (2015)

Hmga2 collaborates with JAK2V617F in the development of myeloproliferative neoplasms
per: Ueda, Koki, et al.
Publicat: (2017)

Generalized Chorea and JAK2V617F Mutation‐Positive Myeloproliferative Disorders
per: Betté, Sagari, et al.
Publicat: (2020)

Transgenic expression of JAK2V617F causes myeloproliferative disorders in mice
per: Shu Xing, et al.
Publicat: (2008)

Widespread occurrence of the JAK2 V617F mutation in chronic myeloproliferative disorders
per: Amy V. Jones
Publicat: (2005)

Classification, Diagnosis and Management of Myeloproliferative Disorders in the JAK2V617F Era
per: Ayalew Tefferi
Publicat: (2006)

Gender and Vascular Complications in the JAK2 V617F-Positive Myeloproliferative Neoplasms
per: Brady L. Stein, et al.
Publicat: (2011)

Genome-Wide Analysis Points to Roles for Extracellular Matrix Remodeling, the Visual Cycle, and Neuronal Development in Myopia
per: Amy K. Kiefer, et al.
Publicat: (2013)

Novel Associations for Hypothyroidism Include Known Autoimmune Risk Loci
per: Nicholas Eriksson, et al.
Publicat: (2012)

The JAK2 46/1 haplotype predisposes to MPL-mutated myeloproliferative neoplasms
per: Jones, Amy V., et al.
Publicat: (2010)

The JAK2 46/1 haplotype predisposes to MPL-mutated myeloproliferative neoplasms
per: Amy V. Jones, et al.
Publicat: (2010)

Detection of the JAK2 V617F Mutation by LightCycler PCR and Probe Dissociation Analysis
per: Lay, Marla, et al.
Publicat: (2006)

Clonal hematopoiesis with JAK2V617F promotes pulmonary hypertension with ALK1 upregulation in lung neutrophils
per: Kimishima, Yusuke, et al.
Publicat: (2021)

Clonal hematopoiesis with JAK2V617F promotes pulmonary hypertension with ALK1 upregulation in lung neutrophils
per: Yusuke Kimishima, et al.
Publicat: (2021)

JAK2 mutants (e.g., JAK2V617F) and their importance as drug targets in myeloproliferative neoplasms
per: Gäbler, Karoline, et al.
Publicat: (2013)